PDCD1 and neoplasm: While CA12 inhibitor or anti–PD-1 alone could reduce tumor metastasis and enhance mouse survival compared with the control treatment groups, the combination of CA12 and PD-1 blockade exhibited much greater efficacy in terms of attenuating tumor metastasis and enhancing OS of mice in vivo (Supplemental Figure 8, A and B).